Product
Supplier
Encyclopedia
Inquiry
Home > Encyclopedia > Proserine

Proserine

pharmaceutical raw materials
Proserine structure

Proserine 

structure
  • CAS No:

    51-60-5

  • Formula:

    C12H19N2O2.CH3O4S

  • Chemical Name:

    Proserine

  • Synonyms:

    Benzenaminium,3-[[(dimethylamino)carbonyl]oxy]-N,N,N-trimethyl-,methyl sulfate (1:1);Ammonium,(m-hydroxyphenyl)trimethyl-,methyl sulfate,dimethylcarbamate;Benzenaminium,3-[[(dimethylamino)carbonyl]oxy]-N,N,N-trimethyl-,methyl sulfate;3-(Dimethylcarbamoxy)phenyl trimethylammonium methyl sulfate;Hodostin;(m-Hydroxyphenyl)trimethylammonium methyl sulfate dimethylcarbamate;(3-Hydroxyphenyl)trimethylammonium methyl sulfate dimethylcarbamic ester;Kirkstigmine methyl sulfate;Leostigmine methyl sulfate;Neoeserine methyl sulfate;Neostigmeth;Neostigmine methosulfate;Neostigmine methyl sulfate;Normastigmin;Philostigmin methyl sulfate;Polstigmine;Proserine methyl sulfate;Stigmanol methyl sulfate;Stigmosan methyl sulfate;Vagostigmine methyl sulfate;Neostigmine mono(methyl sulfate);Prostigmine methyl sulfate;(3-Dimethylcarbamoyloxyphenyl)trimethylammonium methyl sulfate;Eustigmin methyl sulfate;Prostigmin methyl sulfate;Synstigmine;Syntostigmin;Syntostigmin (injection);Vagostigmin;Proserine;GD 65;Stiglyn;Intrastigmina;Metastigmin;NSC 93753;3-[(Dimethylcarbamoyl)oxy]-N,N,N-trimethylanilinium methyl sulfate;Bloxiverz;59954-03-9

  • Categories:

    Organic Chemistry  >  Amides

Description

Neostigmine methyl sulfate is a reversible inhibitor of acetylcholinesterase, can not cross the blood-brain barrier.


Neostigmine methyl sulfate is an arylammonium sulfate salt. It has a role as an EC 3.1.1.8 (cholinesterase) inhibitor.|A cholinesterase inhibitor used in the treatment of myasthenia gravis and to reverse the effects of muscle relaxants such as gallamine and tubocurarine. Neostigmine, unlike PHYSOSTIGMINE, does not cross the blood-brain barrier.

Proserine Basic Attributes

334.39

334.119843

200-109-5

98IMH7M386

93753

DTXSID40199003

2924299090

Characteristics

104

2.11750

white powder

142-145 °C

457ºC

H2O: 1g/10mL

−20°C

Subcutaneous-rat LD50: 0.334 mg/kg; oral-mouse LD50: 7.5 mg/kg

Combustible, decomposes toxic nitrogen oxides, sulfur oxides gas when burning

Safety Information

6.1(a)

UN 2811 6.1/PG 2

3

28-36/37/38-42/43-26/27/28

36-45-36/37/39-28A

CY1225000

T+

Treasury is low temperature, ventilated, dry; stored separately from food raw materials

Stable at normal temperatures and pressures.

Missing Phrase - N15.00950417-P261-P284-P304 + P340-P305 + P351 + P338-P342 + P311

H300-H315-H319-H334-H335

|Danger|H300 (43.3%): Fatal if swallowed [Danger Acute toxicity, oral]|P260, P261, P262, P264, P270, P271, P280, P284, P285, P301+P310, P302+P350, P302+P352, P304+P340, P304+P341, P305+P351+P338, P310, P312, P320, P321, P322, P330, P332+P313, P337+P313, P342+P311, P361, P362, P363, P403+P233, P405, and P501|Aggregated GHS information provided by 97 companies from 7 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.

Toxicity

most toxic

Drug Information

Drugs that inhibit cholinesterases. The neurotransmitter ACETYLCHOLINE is rapidly hydrolyzed, and thereby inactivated, by cholinesterases. When cholinesterases are inhibited, the action of endogenously released acetylcholine at cholinergic synapses is potentiated. Cholinesterase inhibitors are widely used clinically for their potentiation of cholinergic inputs to the gastrointestinal tract and urinary bladder, the eye, and skeletal muscles; they are also used for their effects on the heart and the central nervous system. (See all compounds classified as Cholinesterase Inhibitors.)|Drugs that mimic the effects of parasympathetic nervous system activity. Included here are drugs that directly stimulate muscarinic receptors and drugs that potentiate cholinergic activity, usually by slowing the breakdown of acetylcholine (CHOLINESTERASE INHIBITORS). Drugs that stimulate both sympathetic and parasympathetic postganglionic neurons (GANGLIONIC STIMULANTS) are not included here. (See all compounds classified as Parasympathomimetics.)

Bromide, Neostigmine

Proserine Use and Manufacturing

Methods of Manufacturing

Preparation of neostigmine methylsulphate (General procedure)A 250 ml four neck round bottom flask was charged with 3-dimethylaminophenyl dimethylcarbamate obtained in the example 1, and acetone. Dimethyl sulphate (1.66 eq) was added drop wise to the flask at room temperature. The reaction mixture was stirred overnight, cooled to 5°C to 10°C for 2 hours, filtered and the filtrate was washed with isopropanol. The residue was dried under vacuum at room temperature to get crude neostigmine methylsulphate, which was purified by recrystallisation from isopropanol.Yield - 85percentNature - pale yellow oilHPLC Purity - 99.21percentA clean and dry 1000 ml 4 neck round bottom flask was charged with 3- aminophenyl dimethyl carbamate (50 gm), Calcium carbonate (50 gm) and acetone (300 ml). The reaction mixture was stirred for 5 min. Dimehtyl sulphate (128.3 gm) was added to the reaction mixture and stirred at 25

Uses

Cholinergic; miotic; antidote (curare)

Human Drugs -> FDA Approved Drug Products with Therapeutic Equivalence Evaluations (Orange Book) -> Active Ingredients|Animal Drugs -> FDA Approved Animal Drug Products (Green Book) -> Active Ingredients

Computed Properties

Molecular Weight:334.39
Hydrogen Bond Acceptor Count:6
Rotatable Bond Count:3
Exact Mass:334.11985760
Monoisotopic Mass:334.11985760
Topological Polar Surface Area:104
Heavy Atom Count:22
Complexity:337
Covalently-Bonded Unit Count:2
Compound Is Canonicalized:Yes

Drug Function and Efficacy

It can fully mimetic cholinergic effects by inhibiting the activity of cholinesterase, and can also directly stimulate nicotinic receptors (N2 receptors) on the motor end plates of skeletal muscles. It can promote gastric contraction and increase gastric acid secretion in gastrointestinal smooth muscles, and promote peristalsis of the small and large intestines, especially the colon, thereby preventing intestinal relaxation and promoting the downward movement of intestinal contents. It has a strong excitatory effect on skeletal muscles, but a weak effect on the central nervous system.

This ingredient has been used in drugs with the following functions (note: it does not mean that the ingredient itself has the following health functions)

Related Drugs

Registered Holders

  • ENALTEC LABS PRIVATE LTD

    United States United States
    Active
  • INDOCO REMEDIES LTD

    United States United States
    Active
  • MSN LABORATORIES PRIVATE LTD

    United States United States
    Active

Recommended Suppliers of Proserine

Scan the QR Code to Share

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.